IFNGR1 and cancer: We thus performed mass spectrometry analysis on cancer cells treated with TAK-243 to discover candidate targets and found that IFN pathway effectors, including JAK1 and IFNGR1, were stabilized by TAK-243 treatment (Fig. 5G).